Managing hyperphosphatemia in patients with chronic kidney disease on dialysis with ferric citrate: latest evidence and clinical usefulness.

Yagil, Yoram; Fadem, Stephen Z; Kant, Kotagal S; Bhatt, Udayan; Sika, Mohammed; Lewis, Julia B; Negoi, Dana

Yagil, Yoram; Fadem, Stephen Z; Kant, Kotagal S; Bhatt, Udayan; Sika, Mohammed; Lewis, Julia B; Negoi, Dana.

Afiliación

Yagil Y; Department of Nephrology and Hypertension, Barzilai University Medical Center, 2 Hahistadrut St, Ashkelon 78278, Israel.
Fadem SZ; Division of Nephrology, Baylor College of Medicine, Houston, TX, USA.
Kant KS; Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OH, USA.
Bhatt U; Division of Nephrology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Sika M; Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA.
Lewis JB; Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA.
Negoi D; Department of Nephrology and Hypertension, University of Vermont Medical Group, Burlington, VT, USA.

Ther Adv Chronic Dis ; 6(5): 252-63, 2015 Sep.

Article en En | MEDLINE | ID: mdl-26336594

Palabras clave

efficacy; ferric citrate; hemodialysis; hyperphosphatemia; iron deficiency; safety

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Adv Chronic Dis Año: 2015 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google